Annual Total Expenses
$538.09 M
+$163.00 M+43.45%
December 31, 2024
Summary
- As of March 4, 2025, CORT annual total expenses is $538.09 million, with the most recent change of +$163.00 million (+43.45%) on December 31, 2024.
- During the last 3 years, CORT annual total expenses has risen by +$296.59 million (+122.81%).
- CORT annual total expenses is now at all-time high.
Performance
CORT Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$156.63 M
+$20.68 M+15.21%
December 31, 2024
Summary
- As of March 4, 2025, CORT quarterly total expenses is $156.63 million, with the most recent change of +$20.68 million (+15.21%) on December 31, 2024.
- Over the past year, CORT quarterly total expenses has increased by +$52.89 million (+50.99%).
- CORT quarterly total expenses is now at all-time high.
Performance
CORT Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CORT Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.5% | +51.0% |
| 3 y3 years | +122.8% | +51.0% |
| 5 y5 years | +176.1% | +51.0% |
CORT Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +122.8% | at high | +152.0% |
| 5 y | 5-year | at high | +176.1% | at high | +196.2% |
| alltime | all time | at high | +6621.1% | at high | +7919.9% |
Corcept Therapeutics Incorporated Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $538.09 M(+43.5%) | $156.63 M(+15.2%) |
| Sep 2024 | - | $135.95 M(+6.0%) |
| Jun 2024 | - | $128.20 M(+9.3%) |
| Mar 2024 | - | $117.31 M(+13.1%) |
| Dec 2023 | $375.09 M(+29.7%) | $103.74 M(+12.2%) |
| Sep 2023 | - | $92.42 M(+4.9%) |
| Jun 2023 | - | $88.13 M(-2.9%) |
| Mar 2023 | - | $90.80 M(+12.7%) |
| Dec 2022 | $289.22 M(+19.8%) | $80.56 M(+15.4%) |
| Sep 2022 | - | $69.79 M(-3.0%) |
| Jun 2022 | - | $71.95 M(+7.5%) |
| Mar 2022 | - | $66.92 M(+7.7%) |
| Dec 2021 | $241.50 M(+7.0%) | $62.16 M(+3.8%) |
| Sep 2021 | - | $59.90 M(+0.4%) |
| Jun 2021 | - | $59.65 M(-0.3%) |
| Mar 2021 | - | $59.80 M(+8.3%) |
| Dec 2020 | $225.67 M(+15.8%) | $55.23 M(-10.4%) |
| Sep 2020 | - | $61.61 M(+15.6%) |
| Jun 2020 | - | $53.30 M(-4.0%) |
| Mar 2020 | - | $55.54 M(+5.0%) |
| Dec 2019 | $194.88 M(+20.5%) | $52.88 M(+9.0%) |
| Sep 2019 | - | $48.50 M(+1.8%) |
| Jun 2019 | - | $47.62 M(+3.8%) |
| Mar 2019 | - | $45.87 M(+9.4%) |
| Dec 2018 | $161.75 M(+52.1%) | $41.93 M(+1.1%) |
| Sep 2018 | - | $41.48 M(-0.5%) |
| Jun 2018 | - | $41.68 M(+13.7%) |
| Mar 2018 | - | $36.66 M(+16.1%) |
| Dec 2017 | $106.35 M(+49.5%) | $31.58 M(+8.4%) |
| Sep 2017 | - | $29.14 M(+28.0%) |
| Jun 2017 | - | $22.76 M(-0.4%) |
| Mar 2017 | - | $22.86 M(+21.6%) |
| Dec 2016 | $71.14 M(+32.4%) | $18.80 M(+0.8%) |
| Sep 2016 | - | $18.65 M(+2.4%) |
| Jun 2016 | - | $18.22 M(+17.8%) |
| Mar 2016 | - | $15.47 M(+16.2%) |
| Dec 2015 | $53.73 M(-0.8%) | $13.32 M(+1.2%) |
| Sep 2015 | - | $13.16 M(+0.3%) |
| Jun 2015 | - | $13.12 M(-7.1%) |
| Mar 2015 | - | $14.13 M(+16.9%) |
| Dec 2014 | $54.17 M(+4.5%) | $12.09 M(-2.4%) |
| Sep 2014 | - | $12.38 M(-0.4%) |
| Jun 2014 | - | $12.43 M(-28.0%) |
| Mar 2014 | - | $17.26 M(+22.1%) |
| Dec 2013 | $51.85 M | $14.14 M(+14.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | $12.37 M(-2.4%) |
| Jun 2013 | - | $12.67 M(+0.1%) |
| Mar 2013 | - | $12.66 M(+11.5%) |
| Dec 2012 | $39.58 M(+22.4%) | $11.36 M(+30.2%) |
| Sep 2012 | - | $8.73 M(+3.1%) |
| Jun 2012 | - | $8.47 M(-23.2%) |
| Mar 2012 | - | $11.03 M(+11.1%) |
| Dec 2011 | $32.33 M(+17.8%) | $9.93 M(+54.2%) |
| Sep 2011 | - | $6.44 M(-27.4%) |
| Jun 2011 | - | $8.87 M(+25.0%) |
| Mar 2011 | - | $7.10 M(-9.3%) |
| Dec 2010 | $27.44 M(+35.3%) | $7.82 M(+10.1%) |
| Sep 2010 | - | $7.11 M(+10.2%) |
| Jun 2010 | - | $6.45 M(+6.3%) |
| Mar 2010 | - | $6.06 M(+17.5%) |
| Dec 2009 | $20.28 M(+1.9%) | $5.16 M(+10.6%) |
| Sep 2009 | - | $4.67 M(-4.5%) |
| Jun 2009 | - | $4.89 M(-12.1%) |
| Mar 2009 | - | $5.56 M(-9.8%) |
| Dec 2008 | $19.90 M(+56.3%) | $6.16 M(+24.0%) |
| Sep 2008 | - | $4.97 M(+6.0%) |
| Jun 2008 | - | $4.69 M(+14.8%) |
| Mar 2008 | - | $4.08 M(-7.6%) |
| Dec 2007 | $12.73 M(-50.8%) | $4.42 M(+22.1%) |
| Sep 2007 | - | $3.62 M(+85.3%) |
| Jun 2007 | - | $1.95 M(-28.6%) |
| Mar 2007 | - | $2.74 M(-32.7%) |
| Dec 2006 | $25.88 M(+22.3%) | $4.06 M(-37.9%) |
| Sep 2006 | - | $6.55 M(-19.8%) |
| Jun 2006 | - | $8.16 M(+15.0%) |
| Mar 2006 | - | $7.10 M(+29.0%) |
| Dec 2005 | $21.16 M(+31.9%) | $5.50 M(+0.4%) |
| Sep 2005 | - | $5.48 M(+25.0%) |
| Jun 2005 | - | $4.39 M(-24.2%) |
| Mar 2005 | - | $5.79 M(+4.8%) |
| Dec 2004 | $16.05 M(+60.9%) | $5.52 M(+29.7%) |
| Sep 2004 | - | $4.26 M(+15.3%) |
| Jun 2004 | - | $3.69 M(+43.8%) |
| Mar 2004 | - | $2.57 M(+27.3%) |
| Dec 2003 | $9.97 M(-47.0%) | $2.02 M(-6.7%) |
| Sep 2003 | - | $2.16 M(-26.0%) |
| Jun 2003 | - | $2.92 M(+2.0%) |
| Mar 2003 | - | $2.87 M |
| Dec 2002 | $18.80 M(+134.8%) | - |
| Dec 2001 | $8.01 M | - |
FAQ
- What is Corcept Therapeutics Incorporated annual total expenses?
- What is the all time high annual total expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual total expenses year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly total expenses?
- What is the all time high quarterly total expenses for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly total expenses year-on-year change?
What is Corcept Therapeutics Incorporated annual total expenses?
The current annual total expenses of CORT is $538.09 M
What is the all time high annual total expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual total expenses is $538.09 M
What is Corcept Therapeutics Incorporated annual total expenses year-on-year change?
Over the past year, CORT annual total expenses has changed by +$163.00 M (+43.45%)
What is Corcept Therapeutics Incorporated quarterly total expenses?
The current quarterly total expenses of CORT is $156.63 M
What is the all time high quarterly total expenses for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly total expenses is $156.63 M
What is Corcept Therapeutics Incorporated quarterly total expenses year-on-year change?
Over the past year, CORT quarterly total expenses has changed by +$52.89 M (+50.99%)